Glenmark Pharmaceuticals informs about appointment of CFO

03 Nov 2017 Evaluate

Pursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Glenmark Pharmaceuticals has informed that the Board at its Meeting held on November 2, 2017 has approved the appointment of V. S. Mani as President & Global Chief Financial Officer with effect from November 16, 2017 upon the recommendation of the Nomination and Remuneration Committee. P Ganesh, current President and Global Chief Financial Officer, has tendered his resignation to explore an opportunity outside the Company. The Board places on record its appreciation for contribution made by P Ganesh.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1919.05 -46.70 (-2.38%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×